|
|
|
|
LEADER |
02299nam a2200277 u 4500 |
001 |
EB001999974 |
003 |
EBX01000000000000001162875 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
100 |
1 |
|
|a McNeely, Jennifer
|
245 |
0 |
0 |
|a Substance use screening and risk assessment in adults
|h Elektronische Ressource
|c lead authors, Jennifer McNeely, Angeline Adam, with the Substance Use Guideline Committee
|
260 |
|
|
|a Baltimore, MD
|b Johns Hopkins University
|c 2020, October 2020
|
300 |
|
|
|a 1 PDF file (24 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Substance-Related Disorders / prevention & control
|
653 |
|
|
|a Substance-Related Disorders / diagnosis
|
653 |
|
|
|a Risk Assessment
|
700 |
1 |
|
|a Adam, Angeline
|e [author]
|
710 |
2 |
|
|a New York (State)
|b AIDS Institute
|
710 |
2 |
|
|a Clinical Guidelines Program
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
856 |
4 |
0 |
|u http://www.ncbi.nlm.nih.gov/books/NBK565474
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a This guideline on screening and risk assessment for substance use in adults (≥18 years old) was developed by the New York State (NYS) Department of Health (DOH) AIDS Institute (AI) for use by primary care providers and in other adult outpatient care settings in NYS to achieve the following goals: Increase the identification of unhealthy substance use among NYS residents and increase access to evidence-based interventions for appropriate patients. "Unhealthy substance use" refers to a spectrum of use that increases the risk of health consequences and ranges from hazardous or risky patterns of use to severe substance use disorder (SUD). Increase the number of clinicians in NYS who perform substance use screening and risk assessment as an integral part of primary care. Provide clinicians with guidance on selecting validated substance use screening and risk assessment tools and on providing or referring for evidence-based interventions. Promote a harm reduction approach to the identification and treatment of substance use and SUDs, which involves practical strategies and ideas aimed at reducing the negative consequences associated with substance use
|